Hammond Janet Mj Insider Trades

Insider Trading History

Track insider trading activity for Hammond Janet Mj. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Chief Development Officer
Holding Value $620k 127,665 shares
Last Trade
Jan 31, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$59.9k 14,136 shares
$4.24
$4.86
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Chief Development Officer
Holding Value $689k 141,801 shares
Last Trade
Jan 31, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$246k 58,050 shares
$4.24
$4.86
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Chief Development Officer
Holding Value $860k 177,000 shares
Last Trade
Jan 31, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$750k 177,000 shares
$4.24
$4.86
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Chief Development Officer
Holding Value $0 0 shares
Last Trade
Jan 31, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$47.7k 11,250 shares
$4.24
$4.86
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Chief Development Officer
Holding Value $972k 200,000 shares
Last Trade
Jan 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$612k 200,000 shares
$3.06
$4.86
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Chief Development Officer
Holding Value $410k 84,272 shares
Last Trade
Jan 31, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$143k 46,800 shares
$3.06
$4.86
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Chief Development Officer
Holding Value $396k 81,388 shares
Last Trade
Jan 31, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$43.3k 14,134 shares
$3.06
$4.86
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Chief Development Officer
Holding Value $227k 46,800 shares
Last Trade
Jan 31, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$143k 46,800 shares
$3.06
$4.86
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Chief Development Officer
Holding Value $172k 35,362 shares
Last Trade
Feb 01, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$53.9k 14,029 shares
$3.84
$4.86
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Chief Development Officer
Holding Value $240k 49,391 shares
Last Trade
Jan 31, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$195k 46,800 shares
$4.16
$4.86
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Chief Development Officer
Holding Value $455k 93,600 shares
Last Trade
Jan 31, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$195k 46,800 shares
$4.16
$4.86
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Chief Development Officer
Holding Value $1.09M 225,200 shares
Last Trade
Jan 31, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$937k 225,200 shares
$4.16
$4.86
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Chief Development Officer
Holding Value $955k 196,600 shares
Last Trade
Jan 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$910k 196,600 shares
$4.63
$4.86
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Chief Development Officer
Holding Value $923k 190,000 shares
Last Trade
Jan 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.36M 190,000 shares
$7.14
$4.86
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Chief Development Officer
Holding Value $778k 160,050 shares
Last Trade
Jan 29, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.7M 160,050 shares
$73.00
$4.86
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Chief Development Officer
Holding Value $0 0 shares
Last Trade
Oct 29, 2020 Sale
No data
No data
$4.86

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up